Type III hyperlipidaemia

Also known as: Type III hyperlipidemia / Type III lipidemia / Type III lipidaemia / Remnant hyperlipidaemia / Dysbetalipoproteinaemia / Dysbetalipoproteinemia / Familial type 3 hyperlipoproteinemia (disorder) / Remnant hyperlipidemia / Type III hyperlipoproteinaemia / Type III hyperlipoproteinemia / Hyperlipoproteinemia Type III

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB03756	Doconexent	An omega 3 fatty acid used in a variety of nutritional supplements to support central nervous system and cardiovascular health.

Drug	Drug Name	Target	Type
DB03756	Doconexent	Cytochrome P450 2C9	enzyme
DB03756	Doconexent	Peroxisome proliferator-activated receptor alpha	target
DB03756	Doconexent	Peroxisome proliferator-activated receptor gamma	target
DB03756	Doconexent	Sterol regulatory element-binding protein 1	target
DB03756	Doconexent	Retinoic acid receptor RXR-alpha	target
DB03756	Doconexent	Retinoic acid receptor RXR-beta	target
DB03756	Doconexent	Retinoic acid receptor RXR-gamma	target
DB03756	Doconexent	Myc proto-oncogene protein	target

Drug	Drug Name	Phase	Status	Count